Terms of Use

These Terms of Use (the “Terms”) govern the use of the website www.odimma-therapeutics.com (the “Website”) and define the conditions under which visitors may access and use its content.
By accessing and using the Website, the Visitor acknowledges having read and accepted these Terms without reservation. For the purposes of these Terms, the Website includes www.odimma-therapeutics.com and any other URL that may replace it in the future.
A Visitor is any individual accessing the Website for any purpose whatsoever, including but not limited to obtaining information about the Company and its activities, its therapeutic solutions and product candidates, reading corporate news, or for any other reason.

ARTICLE 1 – ACCEPTANCE
1.1
By accessing the Website, the Visitor acknowledges having read and accepted these Terms of Use.
1.2
The Visitor acknowledges that acceptance of these Terms is full, unconditional and binding, and that no other document or terms, including the Visitor’s own terms of use, shall prevail over these Terms.

ARTICLE 2 – SCOPE
2.1
These Terms apply to every visit to the Website, regardless of its purpose or duration.
2.2
The current version of these Terms is permanently available on the Website. ODIMMA Therapeutics reserves the right to modify these Terms at any time. The applicable version shall be the one published on the Website at the time of consultation.

ARTICLE 3 – LIABILITY
3.1
The information published on the Website and its sources are believed to be reliable. However, ODIMMA Therapeutics makes no representation or warranty as to the accuracy, completeness or relevance of such information. Any errors, omissions or inaccuracies shall not give rise to any liability on the part of ODIMMA Therapeutics.
3.2
The Website contains information and forward-looking statements relating to the activities of ODIMMA Therapeutics, including the development of its product candidates. Such statements are subject to numerous scientific, technical, regulatory, financial and commercial uncertainties that may cause actual results to differ materially from those expressed or implied. The information provided on the Website is for informational purposes only and shall not constitute any contractual commitment.
3.3
ODIMMA Therapeutics is under no obligation to update the information or forward-looking statements published on the Website and encourages Visitors to seek additional information directly from the Company or through independent research sources.
3.4
ODIMMA Therapeutics shall not be held liable for any consequences resulting from changes in applicable laws or regulations that may affect the information contained on the Website.
3.5
While ODIMMA Therapeutics uses reasonable efforts to ensure the security of the Website, it cannot be held liable for any intrusion, virus, malware or other harmful element affecting the Visitor’s equipment or information systems resulting from access to, use of, or downloads from the Website.
3.6
ODIMMA Therapeutics reserves the right to suspend access to the Website for maintenance, updates or modifications and shall not be liable for any temporary interruption or difficulty in accessing the Website or its content.
3.7
The Visitor acknowledges that access to and use of the Website, including downloading or viewing its content, is undertaken at the Visitor’s own risk and responsibility.

ARTICLE 4 – VISITOR OBLIGATIONS
4.1
The Visitor undertakes to use the Website responsibly and to ensure that any device used to access the Website is adequately protected against viruses, malware and unauthorized intrusions.
4.2
Where contact forms are available, the Visitor undertakes to provide accurate, complete and up-to-date information and shall be solely responsible for any consequences resulting from inaccurate or misleading information.
4.3
The Visitor agrees not to interfere with the operation or security of the Website, disrupt its availability, misuse its resources, or engage in any activity that may adversely affect ODIMMA Therapeutics, the Website or its users.
4.4
In the event of a breach of these Terms, ODIMMA Therapeutics reserves the right to take any appropriate action, including notifying the competent authorities and initiating legal proceedings where necessary.

ARTICLE 5 – PERSONAL DATA
5.1
ODIMMA Therapeutics is committed to complying with all applicable personal data protection laws, including Regulation (EU) 2016/679 (General Data Protection Regulation – GDPR).
5.2
For further information regarding the processing of personal data, Visitors are invited to consult the Privacy Policyavailable on the Website.

ARTICLE 6 – INTELLECTUAL PROPERTY
The Website, including its software, databases, structure, text, images, graphics, logos and all other content, is protected by applicable intellectual property laws.
Any reproduction, extraction, modification, reverse engineering, decompilation, distribution, reuse or exploitation of all or part of the Website without the prior written authorization of ODIMMA Therapeutics is strictly prohibited and may give rise to civil and criminal liability.

ARTICLE 7 – GOVERNING LAW AND JURISDICTION
These Terms shall be governed by and construed in accordance with French law.
Any dispute relating to their validity, interpretation or performance shall fall within the exclusive jurisdiction of the Judicial Court of Strasbourg (France).

ARTICLE 8 – ENTRY INTO FORCE
These Terms of Use entered into force upon their publication on the Website.
Published on December 5, 2022.